Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > RBC
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by ANONYM0USon May 13, 2016 9:31pm
180 Views
Post# 24872682

RE:RE:RE:RBC

RE:RE:RE:RBC
Lattice wrote: ANONYMOUS,    RBC Capital Markets also is now publishing a weekly script tracker for Concordia.  The first edition (12 pages) was dated May 10, 2016 which provides investors with a more in depth view of scripts going forward.  It is available through the same Advanced Research tab that the Q1 analysis was posted from today.

if you are not a RBC client, Douglas Miehm's email is douglas.miehm@rbccm.com   


ANONYM0US wrote: Retiredcf....thank you for posting this analysis. How did you arrange to receive a document like this? Is it because you trade through RBC or is it a subscription purchase? I can see this being a very valuable tool. Are these sent out for all mid/large cap financial releases? Thank you




Thank you Lattice
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities